THERAVANCE BIOPHARMA INC financial statements, including revenue, expenses, profit, and loss
The total revenue of 0TB for the last quarter is 13.44 M EUR, and it's 15.54% lower compared to the previous quarter. The net income of Q1 24 is -10.81 M EUR.